ArticleAnalytical and bioanalytical chemistry2026
Long wavelength excitation frequency upconversion xanthene probe for fluorescence detection and imaging of cysteine.
Article in Analytical and bioanalytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
A significant limitation of existing fluorescent probes is their broad reactivity toward multiple biothiols, including cysteine (Cys), homocysteine (Hcy), and glutathione (GSH). The structural similarity and overlapping reactivity of these thiol-containing species present a critical challenge for the selective discrimination of individual targets within complex biological environments. To address this limitation, we present M-Cys, a cysteine-selective frequency upconversion luminescence (FUCL) probe engineered from heteroanthracene-based fluorophores. By utilizing anti-Stokes emission, M-Cys enables near-infrared (NIR) excitation at 808 nm while simultaneously emitting NIR light (742 nm), thereby overcoming the limitations associated with conventional Stokes-shifted probes. This innovative design achieves a three-fold enhancement in sensitivity compared to traditional 690-nm excitation, with a detection limit of 23.2 nM, in contrast to 65.9 nM, attributable to reduced background interference and improved signal-to-noise ratios for FUCL. Comprehensive selectivity assays confirm M-Cys's specificity for cysteine over competing biothiols, thereby ensuring reliable biological discrimination. In addition to in vitro experiments, M-Cys significantly enhances high-contrast imaging of exogenous cysteine in live cells and facilitates in vivo FUCL visualization in murine models. This methodology leverages FUCL's deep tissue penetration and minimal phototoxicity. By integrating unprecedented sensitivity with translational applicability, this study establishes a versatile optical platform that advances high-precision probes for clinical diagnostics.
Indexed as
Identifiers
41263991What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.